CORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON?
- 1 December 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 328 (8520) , 1353-1357
- https://doi.org/10.1016/s0140-6736(86)92004-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.Circulation, 1986
- ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTSThe Lancet, 1986
- Lupus Anticoagulant, Thrombosis, and Fetal LossNew England Journal of Medicine, 1985
- ANTICARDIOLIPIN ANTIBODIES AND LUPUS ANTICOAGULANTThe Lancet, 1984
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- MECHANISM OF ACTION OF THE LUPUS ANTICOAGULANTAnnals of the New York Academy of Sciences, 1981
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.Journal of Clinical Investigation, 1980
- Studies on the Liberation of β‐Thromboglobulin from Human Platelets in VitroBritish Journal of Haematology, 1976